{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:15:25Z","timestamp":1771557325174,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuro.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T16:05:00Z","timestamp":1727193900000},"page":"131-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Saroglitazar, a PPAR \u03b1\/\u03b3 agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms"],"prefix":"10.1016","volume":"105","author":[{"given":"Madhuri Suma","family":"Jakkamsetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aravinda Sai","family":"Kolusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suma","family":"Rongala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu Prakash","family":"Arakareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi Prashanthi","family":"Nori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan Kumar","family":"Samudrala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2024.09.004_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10495-020-01645-x","article-title":"Potential role of {TrkB} agonist in neuronal survival by promoting {CREB}\/{BDNF} and {PI3K}\/{Akt} signaling in vitro and in vivo model of 3-nitropropionic acid (3-{NP})-induced neuronal death","volume":"26","author":"Ahmed","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuro.2024.09.004_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40360-021-00524-8","article-title":"Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis","volume":"22","author":"Akbari","year":"2021","journal-title":"BMC Pharm. Toxicol."},{"key":"10.1016\/j.neuro.2024.09.004_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2018.12.014","article-title":"Astaxanthin ameliorates scopolamine-induced spatial memory deficit via reduced cortical-striato-hippocampal oxidative stress","volume":"1710","author":"Al-Amin","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuro.2024.09.004_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112866","article-title":"Beta-Boswellic acid reverses 3-nitropropionic acid-induced molecular, mitochondrial, and histopathological defects in experimental rat model of Huntington\u2019s disease","volume":"Vol. 10","author":"Albekairi","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuro.2024.09.004_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12640-021-00462-7","article-title":"Anti-Huntington\u2019s effect of butin in 3-nitropropionic acid-treated rats: possible mechanism of action","volume":"40","author":"Alshehri","year":"2022","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.neuro.2024.09.004_bib6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopha.2018.03.115","article-title":"Bergenia ciliata ameliorates streptozotocin-induced spatial memory deficits through dual cholinesterase inhibition and attenuation of oxidative stress in rats","volume":"102","author":"Barai","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/dneu.20781","article-title":"Neurotrophic factor control of adult {SVZ} neurogenesis","volume":"70","author":"Bath","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neuro.2024.09.004_bib8","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in {Huntington}\u2019s disease","volume":"448","author":"Bennett","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2024.09.004_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2005.06.019","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor \u03b1 agonist, exerts neuroprotective effects in traumatic brain injury","volume":"388","author":"Besson","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2024.09.004_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2011.10.029","article-title":"Peroxisome proliferator-activated receptor-\u03b1 activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms","volume":"674","author":"Bhateja","year":"2012","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14306","article-title":"Neuroprotective potential of saroglitazar in 6-OHDA induced Parkinson\u2019s disease in rats","author":"Bhatt","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.neuro.2024.09.004_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2\u2013ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"157","author":"Buendia","year":"2016","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.neuro.2024.09.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuro.2024.09.004_bib15","doi-asserted-by":"crossref","unstructured":"Chen, X.R., Besson, V.C., Palmier, B., Garcia, Y., Plotkine, M., Marchand-Leroux, C., 2007. Neurological Recovery-Promoting, Anti-Inflammatory, and Anti-Oxidative Effects Afforded by Fenofibrate, a PPAR Alpha Agonist, in Traumatic Brain Injury. \u3008https:\/\/home.liebertpub.com\/neu\u3009 24, 1119\u20131131. https:\/\/doi.org\/10.1089\/NEU.2006.0216.","DOI":"10.1089\/neu.2006.0216"},{"key":"10.1016\/j.neuro.2024.09.004_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bcp.2017.07.021","article-title":"Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: {Critical} role of {PPAR}-\u03b3 signaling pathway","volume":"144","author":"Choi","year":"2017","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.biopha.2018.06.079","article-title":"Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington\u2019s disease-like symptoms in rats","volume":"105","author":"Danduga","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuro.2024.09.004_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/TCRM.S17152","article-title":"Management of {Huntington}\u2019s disease: role of tetrabenazine","volume":"7","author":"de Tommaso","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.neuro.2024.09.004_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biopha.2016.03.017","article-title":"Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats","volume":"81","author":"Deshmukh","year":"2016","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","article-title":"Effect of embelin against 3-nitropropionic acid-induced Huntington\u2019s disease in rats","volume":"77","author":"Dhadde","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuro.2024.09.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119191","article-title":"Saroglitazar, a novel dual PPAR-\u03b1\/\u03b3 agonist, reverses high fat-low protein diet-induced metabolic and cognitive aberrations in C57BL\/6J male mice","volume":"271","author":"Dharavath","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.neuro.2024.09.004_bib22","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.0367-19.2019","article-title":"CREB family transcription factors are major mediators of BDNF transcriptional autoregulation in cortical neurons","volume":"40","author":"Esvald","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib23","unstructured":"FDA approves first drug to treat tardive dyskinesia | FDA [WWW Document], n.d. URL \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-treat-tardive-dyskinesia\u3009 (accessed 9.5.24)."},{"key":"10.1016\/j.neuro.2024.09.004_bib24","article-title":"Natural acetylcholinesterase inhibitors: a multi-targeted therapeutic potential in Alzheimer\u2019s disease","volume":"11","author":"Gajendra","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.neuro.2024.09.004_bib25","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib26","series-title":"Mood and {Anxiety} {Related} {Phenotypes} in {Mice}: {Characterization} {Using} {Behavioral} {Tests}, Neuromethods.","first-page":"1","article-title":"The {Open} {Field} {Test}","author":"Gould","year":"2009"},{"key":"10.1016\/j.neuro.2024.09.004_bib27","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1523\/JNEUROSCI.2051-07.2007","article-title":"cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response","volume":"27","author":"Gur","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0306-4522(97)00192-9","article-title":"Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats","volume":"81","author":"Guyot","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2024.09.004_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175046","article-title":"Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK","volume":"927","author":"Habib","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib30","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"{PPARs} in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuro.2024.09.004_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2013.12.033","article-title":"Docosahexaenoic acid confers enduring neuroprotection in experimental stroke","volume":"338","author":"Hong","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuro.2024.09.004_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnrt.2022.100002","article-title":"Acetylcholine bidirectionally regulates learning and memory","volume":"10","author":"Huang","year":"2022","journal-title":"J. Neurorestoratology"},{"key":"10.1016\/j.neuro.2024.09.004_bib33","unstructured":"Huntington\u2019s disease | NHS inform | NHS inform [WWW Document], n.d. URL \u3008https:\/\/www.nhsinform.scot\/illnesses-and-conditions\/brain-nerves-and-spinal-cord\/huntingtons-disease\/\u3009 (accessed 9.5.24)."},{"key":"10.1016\/j.neuro.2024.09.004_bib34","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s10787-022-01004-z","article-title":"Diapocynin neuroprotective effects in 3-nitropropionic acid {Huntington}\u2019s disease model in rats: emphasis on {Sirt1}\/{Nrf2} signaling pathway","volume":"30","author":"Ibrahim","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuro.2024.09.004_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2015.10.033","article-title":"Antidepressants for neuroprotection in {Huntington}\u2019s disease: {A} review","volume":"769","author":"Jamwal","year":"2015","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/142129","article-title":"Electroacupuncture {Treatment} {Improves} {Learning}-{Memory} {Ability} and {Brain} {Glucose} {Metabolism} in a {Mouse} {Model} of {Alzheimer}\u2019s {Disease}: {Using} {Morris} {Water} {Maze} and {Micro}-{PET}","volume":"2015","author":"Jiang","year":"2015","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.neuro.2024.09.004_bib37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00673","article-title":"Schisandra chinensis stem ameliorates 3-nitropropionic acid-induced striatal toxicity via activation of the nrf2 pathway and inhibition of the MAPKs and NF-\u03baB pathways","volume":"8","author":"Kim","year":"2017","journal-title":"Front. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib39","first-page":"1","article-title":"The PPAR \u03b1\/\u03b3 agonist saroglitazar improves insulin resistance and steatohepatitis in a diet induced animal model of nonalcoholic fatty liver disease","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuro.2024.09.004_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2018.01.002","article-title":"Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue","volume":"822","author":"Kumar","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/01480541003642050","article-title":"Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain","volume":"33","author":"Kumar","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neuro.2024.09.004_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/brainsci10010043","article-title":"Therapeutic {Advances} for {Huntington}\u2019s {Disease}","volume":"10","author":"Kumar","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuro.2024.09.004_bib43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neures.2009.01.005","article-title":"Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide","volume":"63","author":"Kumar","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuro.2024.09.004_bib44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1472-8206.2007.00485.x","article-title":"Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms","volume":"21","author":"Kumar","year":"2007","journal-title":"Fundam. Clin. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1471-4159.2009.06331.x","article-title":"Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid","volume":"111","author":"Lagoa","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2024.09.004_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1602\/neurorx.1.1.128","article-title":"The paradigm of Huntington\u2019s disease: Therapeutic opportunities in neurodegeneration","volume":"1","author":"Leegwater-Kim","year":"2004","journal-title":"NeuroRX"},{"key":"10.1016\/j.neuro.2024.09.004_bib47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.intimp.2017.05.036","article-title":"Pioglitazone attenuates lipopolysaccharide-induced depression-like behaviors, modulates {NF}-\u03ba{B}\/{IL}-6\/{STAT3}, {CREB}\/{BDNF} pathways and central serotonergic neurotransmission in mice","volume":"49","author":"Liao","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuro.2024.09.004_bib48","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/bph.13843","article-title":"Neurosteroid biosynthesis down-regulation and changes in {GABAA} receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment","volume":"174","author":"Locci","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopsych.2019.02.006","article-title":"Stimulation of {Peroxisome} {Proliferator}-{Activated} {Receptor}-\u03b1 by {N}-{Palmitoylethanolamine} {Engages} {Allopregnanolone} {Biosynthesis} to {Modulate} {Emotional} {Behavior}","volume":"85","author":"Locci","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuro.2024.09.004_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuro.2024.09.004_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","article-title":"{BDNF} and synaptic plasticity, cognitive function, and dysfunction","volume":"220","author":"Lu","year":"2014","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.neuro.2024.09.004_bib52","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/acschemneuro.0c00824","article-title":"Protective effect of natural products against Huntington\u2019s disease: an overview of scientific evidence and understanding their mechanism of action","volume":"12","author":"Lum","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"10.1016\/j.neuro.2024.09.004_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117729","article-title":"Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-\u03b2\/Smad signaling pathway","volume":"253","author":"Makled","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.neuro.2024.09.004_bib55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/B978-0-12-804239-7.00055-X","article-title":"Neuroinflammation and oxidative injury in developmental neurotoxicity","author":"Milatovic","year":"2017","journal-title":"Reprod. Dev. Toxicol."},{"key":"10.1016\/j.neuro.2024.09.004_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid {X} receptors in the adult rat {CNS}","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2024.09.004_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0023-9690(81)90020-5","article-title":"Spatial localization does not require the presence of local cues","volume":"12","author":"Morris","year":"1981","journal-title":"Learn Motiv"},{"key":"10.1016\/j.neuro.2024.09.004_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in {Alzheimer}\u2019s disease and {Parkinson}\u2019s disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuro.2024.09.004_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2020.01.118","article-title":"Pemafibrate, a selective PPAR\u03b1 modulator, and fenofibrate suppress microglial activation through distinct PPAR\u03b1 and SIRT1-dependent pathways","volume":"524","author":"Ogawa","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuro.2024.09.004_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuro.2024.09.004_bib61","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.13005\/bpj\/1830","article-title":"Amelioration of {Oxidative} {Stress} and {Neuroinflammation} by {Saroglitazar}, a {Dual} {PPAR\u03b1}\/\u03b3 {Agonist} in {MES} {Induced} {Epileptic} {Rats}","volume":"12","author":"Panigrahy","year":"2019","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.neuro.2024.09.004_bib62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12640-013-9437-9","article-title":"Role of nuclear receptor on regulation of {BDNF} and neuroinflammation in hippocampus of \u03b2-amyloid animal model of {Alzheimer}\u2019s disease","volume":"25","author":"Prakash","year":"2014","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.neuro.2024.09.004_bib63","first-page":"1","article-title":"Ameliorative effect of ferulic acid on thyroid dysfunction against propyl-thiouracil induced hypothyroid rats","author":"Rongala","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.neuro.2024.09.004_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neuro.2024.09.004_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.celrep.2013.07.028","article-title":"Regulation of cyclic {AMP} response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor \u03b1","volume":"4","author":"Roy","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuro.2024.09.004_bib66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cmet.2015.05.022","article-title":"{HMG}-{CoA} {Reductase} {Inhibitors} {Bind} to {PPAR\u03b1} to {Upregulate} {Neurotrophin} {Expression} in the {Brain} and {Improve} {Memory} in {Mice}","volume":"22","author":"Roy","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuro.2024.09.004_bib67","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nchembio.2204","article-title":"Identification and characterization of {PPAR\u03b1} ligands in the hippocampus","volume":"12","author":"Roy","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuro.2024.09.004_bib68","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1021\/acschemneuro.3c00320","article-title":"Neuroprotective effect of saroglitazar on scopolamine-induced Alzheimer\u2019s in rats: insights into the underlying mechanisms","volume":"14","author":"Sandeep Ganesh","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/373560","article-title":"Neuroprotective {Mechanisms} of {PPAR\u03b4}: {Modulation} of {Oxidative} {Stress} and {Inflammatory} {Processes}","volume":"2011","author":"Schnegg","year":"2011","journal-title":"PPAR Res"},{"key":"10.1016\/j.neuro.2024.09.004_bib70","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","article-title":"Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of {Huntington}\u2019s disease","volume":"22","author":"Shear","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Pt A","key":"10.1016\/j.neuro.2024.09.004_bib71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2014.05.019","article-title":"Nuclear receptors in neurodegenerative diseases","volume":"72","author":"Skerrett","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2024.09.004_bib72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuroscience.2006.01.045","article-title":"Histamine improves rat rota-rod and balance beam performances through H2 receptors in the cerebellar interpositus nucleus","volume":"140","author":"Song","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2024.09.004_bib73","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1474-4422(23)00127-8","article-title":"Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington\u2019s disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"22","author":"Stimming","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuro.2024.09.004_bib74","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11011-016-9929-4","article-title":"Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on {Huntington}\u2019s disease model in rats","volume":"32","author":"Suganya","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuro.2024.09.004_bib75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(99)00763-6","article-title":"Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain","volume":"275","author":"Sugino","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2024.09.004_bib76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2008.07.007","article-title":"New insights into brain {BDNF} function in normal aging and {Alzheimer} disease","volume":"59","author":"Tapia-Arancibia","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuro.2024.09.004_bib77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17460441.2023.2201493","article-title":"Animal models of Huntington\u2019s disease and their applicability to novel drug discovery and development","volume":"18","author":"Upadhayay","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.neuro.2024.09.004_bib78","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s43440-024-00619-z","article-title":"Mitochondrial targeted antioxidants as potential therapy for huntington\u2019s disease","volume":"76","author":"Upadhayay","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuro.2024.09.004_bib79","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s11064-023-03868-1","article-title":"An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a Huntington\u2019s disease model and its relevance to drug discovery and development","volume":"48","author":"Upadhayay","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuro.2024.09.004_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/srep27618","article-title":"Localization of {PPAR} isotypes in the adult mouse and human brain","volume":"6","author":"Warden","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuro.2024.09.004_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.657338","article-title":"Purinergic {Signaling} in the {Pathophysiology} and {Treatment} of {Huntington}\u2019s {Disease}","volume":"15","author":"Wiprich","year":"2021","journal-title":"Front Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib82","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1460-9568.2004.03246.x","article-title":"The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition","volume":"19","author":"Wu","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuro.2024.09.004_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0930-6","article-title":"Brain-derived neurotrophic factor reduces inflammation and hippocampal apoptosis in experimental Streptococcus pneumoniae meningitis","volume":"14","author":"Xu","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neuro.2024.09.004_bib84","article-title":"Tetramethylpyrazine ameliorates high glucose-induced endothelial dysfunction by increasing mitochondrial biogenesis","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2024.09.004_bib85","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/0118715273258337230925040049","article-title":"Montelukast ameliorates scopolamine-induced Alzheimer\u2019s disease: role on cholinergic neurotransmission, antioxidant defence system, neuroinflammation and expression of BDNF","volume":"23","author":"Yerraguravagari","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuro.2024.09.004_bib86","first-page":"5100","article-title":"Vildagliptin, a {DPP4} inhibitor, alleviates diabetes-associated cognitive deficits by decreasing the levels of apoptosis-related proteins in the rat hippocampus","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuro.2024.09.004_bib87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X24001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X24001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:44:01Z","timestamp":1734000241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X24001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":87,"alternative-id":["S0161813X24001177"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2024.09.004","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saroglitazar, a PPAR \u03b1\/\u03b3 agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}